Actiphage Archives - PBD Biotech

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been revealed by the TAG pipeline report

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been...

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022

A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022

A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022

Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022

Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session...

From Farm to Fork, the power of phage

February 24, 2022

Phage diagnostics have potential for cost-effective detection of bacterial infections across medical, food, and agricultural industries says new review.

From Farm to Fork, the power of phage

February 24, 2022

Phage diagnostics have potential for cost-effective detection of bacterial infections across medical, food, and agricultural industries says new review.

Could a rapid diagnostic help reduce infection risk?

February 14, 2022

Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health systems, according to the Centres for Disease Control and Prevention (CDC)

Could a rapid diagnostic help reduce infection risk?

February 14, 2022

Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health...

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022

“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022

“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...

Phage Based Diagnostics

Actiphage

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

From Farm to Fork, the power of phage

From Farm to Fork, the power of phage

Could a rapid diagnostic help reduce infection risk?

Could a rapid diagnostic help reduce infection risk?

Disruptive phage technology attracts top scientist to PBD Biotech

Disruptive phage technology attracts top scientist to PBD Biotech

developers of phage-based diagnostics